Sun Pharmaceutical Industries Inc. is recalling 12,960 vials of Amphotericin B Liposome for Injection (50mg per vial). This medication, used to treat serious fungal infections, was found to be subpotent, which means it may not contain the full amount of medicine needed to be effective. No incidents or injuries have been reported to date regarding this recall.
If a patient receives a subpotent dose of this antifungal medication, the treatment may fail to control their serious fungal infection, potentially leading to a worsening of their medical condition.
Quantity: 12,960 vials; Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512; Manufactured by Sun Pharmaceutical Medicare Limited, Gujarat, India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.